Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to Buy Fulcrum Therapeutics Stock (FULC)

Buy Fulcrum Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Fulcrum Therapeutics is a biotechnology business based in the US. Fulcrum Therapeutics shares (FULC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.36 – an increase of 9.28% over the previous week. Fulcrum Therapeutics employs 45 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Fulcrum Therapeutics stock

How to buy Fulcrum Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – FULC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Fulcrum Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
12 of 12 results
Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY bullet point infobox
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.01%
ENDS SOON!
$150
$150
VISA CARD SIGNUP BONUS
1
Join Finder
2
Sign up to SoFi and make a $1,000 deposit
3
Get a digital Visa gift card from Finder
Get up to $1,000 in stock when you open and fund a new account. T&Cs apply.
Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Event contracts, High-yield cash account
$0
$0
3.75%
Get a free stock when you successfully sign up and link your bank account. T&Cs apply.
Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Investments, Retirement, Treasury Bills, High-yield cash account
$0
$0
3.8%
Get up to $10,000 and transfer fees covered when you move your portfolio to Public. T&Cs apply.
Build a diversified portfolio of stocks, bonds, options, ETFs and crypto, with a high-yield cash account and options contract rebates.
Webull logo
Finder score
Finder score
Stocks, Bonds, Options, ETFs, Futures, Money market funds
$0
$0
3.85%
Deposit or transfer $100,000+ to earn a 4% Match Bonus, or $2,000+ to earn a 3% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&Cs apply.
Trade stocks, ETFs and equity options commission-free, with access to futures, advanced charting tools, a robo-advisor and event trading powered by Kalshi.
Interactive Brokers logo
Finder score
Finder score
Stocks, Options, Mutual funds, ETFs, Cryptocurrency
$0
$0
3.83% Lite
4.83% Pro
Trade in a simulated trading environment and access a wide range of tradable assets.
eToro logo
Finder score
Finder score
Stocks, Options, ETFs, Cryptocurrency, Investments
$0
$0
3.75%
No commission stock, ETF and options trades, with 3.9% interest on your options account balance and no options contract fees. See full disclosure.
Zacks Trade logo
Finder score
Finder score
Stocks, Bonds, Options, Mutual funds, ETFs, CDs
$0.01
$250
2.83%
Leverage powerful trading tools and low margin rates to trade stocks, options, ETFs, mutual funds and bonds.
Acorns logo
Finder score
Finder score
Stocks, ETFs
$0
$0
N/A
Get a $20 bonus when you set up an account and make your first recurring investment (min. $5). T&Cs apply.
Automate investing with recurring contributions starting at $5 and invest spare change from everyday purchases.
Stash Investments LLC logo
Finder score
Finder score
Stocks, ETFs
$0
$0
0.1%
Get $5 when you sign up and deposit $5. T&Cs apply.
Bank, automate your portfolio or invest in individual stocks and ETFs for as low as $3 per month.
Wealthfront logo
Finder score
Finder score
Stocks, ETFs, High-yield cash account
$0
$500
3.75%
Get a $50 bonus when you sign up and fund a taxable automated investing account with at least $500. T&Cs apply.
Automate your stock and bond portfolio or trade individual stocks for as little as $1 apiece. Plus, earn 3.75% APY on your cash.
JPMorgan logo
Finder score
Finder score
Mutual funds, ETFs
$0
$25,000
N/A
Financial planning, advice and portfolio management. T&Cs apply.
Get ongoing access to an advisory team with personalized financial planning and expert-built portfolios. Provider terms & conditions apply
M1 Finance logo
Finder score
Finder score
Stocks, ETFs, Cryptocurrency
$0
$100
4.00%
Build a custom portfolio of stocks and ETFs with automatic rebalancing. Plus, earn 4.00% APY with a high-yield cash account.
loading
Showing 12 of 12 results

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Fulcrum Therapeutics stock price (NASDAQ: FULC)

Use our graph to track the performance of FULC stocks over time.

Fulcrum Therapeutics shares at a glance

Information last updated 2025-11-11.
Latest market close$8.36
52-week range$2.32 - $10.11
50-day moving average $8.38
200-day moving average $6.05
Wall St. target price$13.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-1.14

Is it a good time to buy Fulcrum Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fulcrum Therapeutics price performance over time

Historical closes compared with the close of $7.67 from 2025-11-10

1 week (2025-11-06) 0.26%
1 month (2025-10-13) -12.34%
3 months (2025-08-13) 11.97%
6 months (2025-05-13) 32.47%
1 year (2024-11-13) 115.45%
2 years (2023-11-13) 121.04%
3 years (2022-11-11) 7.42%
5 years (2020-11-13) 12.65

Fulcrum Therapeutics financials

Gross profit TTM $-52,400,000
Return on assets TTM -20.63%
Return on equity TTM -31.21%
Profit margin 0%
Book value $3.67
Market Capitalization $441.1 million

TTM: trailing 12 months

Fulcrum Therapeutics share dividends

We're not expecting Fulcrum Therapeutics to pay a dividend over the next 12 months.

Fulcrum Therapeutics share price volatility

Over the last 12 months, Fulcrum Therapeutics's shares have ranged in value from as little as $2.315 up to $10.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulcrum Therapeutics's is 3.185. This would suggest that Fulcrum Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Fulcrum Therapeutics overview

Fulcrum Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc.

Frequently asked questions

null
What percentage of Fulcrum Therapeutics is owned by insiders or institutions?
Currently 1.529% of Fulcrum Therapeutics shares are held by insiders and 101.477% by institutions.
How many people work for Fulcrum Therapeutics?
Latest data suggests 45 work at Fulcrum Therapeutics.
When does the fiscal year end for Fulcrum Therapeutics?
Fulcrum Therapeutics's fiscal year ends in December.
Where is Fulcrum Therapeutics based?
Fulcrum Therapeutics's address is: 26 Landsdowne Street, Cambridge, MA, United States, 02139
What is Fulcrum Therapeutics's ISIN number?
Fulcrum Therapeutics's international securities identification number is: US3596161097
What is Fulcrum Therapeutics's CUSIP number?
Fulcrum Therapeutics's Committee on Uniform Securities Identification Procedures number is: 359616109

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site